🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/08/2004 | 14,93 | 14,95 | 14,59 | 14,86 | -0,47% | 2,45% | 1.375.600 |
| 30/08/2004 | 15,60 | 15,66 | 14,84 | 14,93 | -6,69% | 5,26% | 2.246.000 |
| 27/08/2004 | 15,81 | 16,16 | 15,79 | 16,00 | +1,62% | 2,34% | 820.600 |
| 26/08/2004 | 16,00 | 16,00 | 15,64 | 15,74 | -1,63% | 2,25% | 654.000 |
| 25/08/2004 | 15,97 | 16,00 | 15,46 | 16,00 | +0,41% | 3,38% | 693.400 |
| 24/08/2004 | 15,76 | 16,03 | 15,68 | 15,94 | +1,24% | 2,25% | 784.400 |
| 23/08/2004 | 15,44 | 15,83 | 15,23 | 15,74 | +1,98% | 3,92% | 1.056.200 |
| 20/08/2004 | 15,23 | 15,44 | 15,05 | 15,44 | +1,65% | 2,53% | 533.400 |
| 19/08/2004 | 15,06 | 15,33 | 14,95 | 15,19 | +0,46% | 2,49% | 601.000 |
| 18/08/2004 | 14,76 | 15,17 | 14,69 | 15,12 | +2,37% | 3,25% | 769.000 |
| 17/08/2004 | 14,65 | 15,00 | 14,62 | 14,77 | +1,48% | 2,63% | 811.800 |
| 16/08/2004 | 14,17 | 14,75 | 14,17 | 14,55 | +1,96% | 4,13% | 813.400 |
| 13/08/2004 | 14,15 | 14,56 | 14,14 | 14,27 | +1,53% | 3,00% | 1.023.000 |
| 12/08/2004 | 13,91 | 14,61 | 13,88 | 14,06 | +0,36% | 5,29% | 952.000 |
| 11/08/2004 | 14,16 | 14,46 | 13,90 | 14,01 | -2,17% | 3,96% | 3.295.800 |
| 10/08/2004 | 14,53 | 14,78 | 14,06 | 14,32 | -1,04% | 4,96% | 1.645.800 |
| 09/08/2004 | 14,95 | 15,05 | 14,34 | 14,47 | -3,05% | 4,75% | 1.168.200 |
| 06/08/2004 | 14,95 | 15,08 | 14,71 | 14,92 | -1,36% | 2,44% | 1.722.000 |
| 05/08/2004 | 14,92 | 15,40 | 14,70 | 15,13 | -0,17% | 4,73% | 2.425.400 |
| 04/08/2004 | 13,92 | 15,50 | 13,78 | 15,15 | +8,02% | 12,40% | 5.016.800 |
| 03/08/2004 | 13,25 | 14,30 | 13,00 | 14,03 | +16,68% | 9,81% | 7.135.000 |
| 02/08/2004 | 12,31 | 12,45 | 12,02 | 12,02 | -2,91% | 3,45% | 237.000 |
| 30/07/2004 | 11,88 | 12,43 | 11,88 | 12,38 | +3,69% | 4,63% | 418.400 |
| 29/07/2004 | 11,88 | 11,97 | 11,68 | 11,94 | +1,36% | 2,44% | 185.800 |
| 28/07/2004 | 11,75 | 11,97 | 11,43 | 11,78 | -0,04% | 4,60% | 457.000 |
| 27/07/2004 | 11,55 | 11,99 | 11,48 | 11,79 | +1,81% | 4,37% | 827.200 |
| 26/07/2004 | 11,73 | 11,81 | 11,45 | 11,58 | -1,36% | 3,07% | 368.800 |
| 23/07/2004 | 11,82 | 12,03 | 11,68 | 11,74 | -1,72% | 2,92% | 232.600 |
| 22/07/2004 | 11,68 | 11,96 | 11,43 | 11,94 | +1,83% | 4,50% | 1.562.600 |
| 21/07/2004 | 12,60 | 12,60 | 11,68 | 11,73 | -6,31% | 7,26% | 520.800 |